BioNeex Interviews
CPTx
May 13, 2025
The CTO of CPTx, Christian Sigl is talking about their revolutionary platform technology centered on creating DNA nanostructures.
CPTx’s current focus is the infectious disease space, creating a therapeutic platform to neutralize virus infections, starting with influenza. The company is building nanometer sized backbone that are armed with a virus-binding molecule to trap and neutralize virus particles making them incapable of infecting other cells.
Back 
Interview URL has been copied in the clipboard